Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivitrol Feasibility in Drug Court Settings
NCT02978417Phase 4Completed
- Sponsor
- Duke University
- Start
- Sep 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of naltrexone in opioid use disorder (OUD) (2 arms), sponsored by Duke University. Primary endpoints: Number of Participants With New Arrests at 12 months and Number of Participants With New Incarcerations at 12 months. Started Sep 2017; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02978417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02978417.